Avedro, Inc. to Present at the Guggenheim MedTech Disruptors Summit
20 Mai 2019 - 10:05PM
Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), today announced the company
will be participating in the upcoming Guggenheim MedTech Disruptors
Summit in New York, NY.
Avedro’s management is scheduled to present on Wednesday, May
29, 2019, at 4:10 PM Eastern Time. Interested parties may access a
live and archived webcast of the presentation on the “Investors”
section of the company’s website at www.avedro.com.
About Avedro, Inc.
Avedro is a leading commercial-stage ophthalmic medical
technology company focused on treating corneal ectatic disorders
and improving vision to reduce dependency on eyeglasses or contact
lenses. Avedro’s proprietary Avedro Corneal Remodeling Platform is
designed to strengthen, stabilize and reshape the cornea utilizing
corneal cross-linking in minimally invasive and non-invasive
outpatient procedures to treat corneal ectatic disorders and
correct refractive conditions. The Avedro Corneal Remodeling
Platform is comprised of Avedro’s KXL and Mosaic systems, each of
which delivers ultraviolet A light, and a suite of proprietary
single-use riboflavin drug formulations, which, when applied
together to the cornea, induce a biochemical reaction called
corneal collagen cross-linking.
Avedro Contact: |
Investor Contact: |
David Iannetta |
Greg Chodaczek or Lynn Lewis |
781-768-3400 |
646-924-1769 |
info@avedro.com |
investors@avedro.com |
Avedro (NASDAQ:AVDR)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Avedro (NASDAQ:AVDR)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Avedro Inc (NASDAQ): 0 recent articles
Plus d'articles sur